The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Raloxifene Hydrochloride 60mg Film-coated Tablets

60 milligram(s) Film-coated tablet

Accord Healthcare Ireland Ltd.PA2315/095/001

Main Information

Trade NameRaloxifene Hydrochloride 60mg Film-coated Tablets
Active SubstancesRaloxifene Hydrochloride
Strength60 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/095/001

Group Information

ATC CodeG03XC Selective estrogen receptor modulators
G03XC01 raloxifene

Status

Authorised/WithdrawnAuthorised
Licence Issued30/01/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back